Production (Stage)
Verve Therapeutics, Inc.
VERV
$4.36
-$0.02-0.46%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -18.02% | -15.97% | 11.27% | 24.54% | 19.20% |
| Total Receivables | -75.74% | -44.80% | -16.44% | 45.25% | 310.75% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 60.82% | 87.79% | 40.66% | 40.04% | 6.44% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -17.52% | -14.92% | 11.68% | 24.91% | 19.80% |
|
|
|||||
| Total Current Assets | -17.52% | -14.92% | 11.68% | 24.91% | 19.80% |
| Net Property, Plant & Equipment | -9.45% | -10.27% | -7.69% | -7.35% | -5.86% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.80% | 14.07% | 25.37% | 33.82% | 35.19% |
| Total Assets | -16.14% | -13.99% | 8.41% | 18.97% | 15.45% |
|
|
|||||
| Total Accounts Payable | 75.53% | -31.89% | 339.94% | 117.20% | -9.58% |
| Total Accrued Expenses | 3.03% | 23.70% | -5.45% | -0.39% | -12.87% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.90% | 2.45% | 2.47% | 2.46% | -8.62% |
| Total Finance Division Other Current Liabilities | 1,193.96% | 621.00% | 1,577.87% | 1,122.26% | -- |
| Total Other Current Liabilities | 1,193.96% | 621.00% | 1,577.87% | 1,122.26% | -- |
| Total Current Liabilities | 66.11% | 15.95% | 23.33% | 22.21% | -6.73% |
|
|
|||||
| Total Current Liabilities | 66.11% | 15.95% | 23.33% | 22.21% | -6.73% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -8.41% | -8.00% | -8.70% | -8.31% | -7.94% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -43.99% | 0.15% | 2.07% | 126.66% | 143.25% |
| Total Liabilities | -5.79% | 0.53% | 2.18% | 24.94% | 19.53% |
|
|
|||||
| Common Stock & APIC | 6.00% | 8.08% | 25.44% | 29.84% | 29.88% |
| Retained Earnings | -30.52% | -36.51% | -39.73% | -42.79% | -49.68% |
| Treasury Stock & Other | 178.60% | 57.35% | 291.46% | 18.44% | -110.97% |
| Total Common Equity | -18.79% | -17.70% | 10.47% | 17.38% | 14.44% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -18.79% | -17.70% | 10.47% | 17.38% | 14.44% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -18.79% | -17.70% | 10.47% | 17.38% | 14.44% |
|
|
|||||